Optimizing adenoviral transduction of endothelial cells under flow conditions

Pharmaceutical Research

Volumn 29, Issue 5, 2012, Pages 1219-1231

  Anton, Martina ^a   Wolf, Anja ^a   Mykhaylyk, Olga ^a   Koch, Christian ^a   Gansbacher, Bernd ^a   Plank, Christian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Adenoviral vectors; Endothelial cells; Gene transfer; Magnetic nanoparticles; Shielding

Indexed keywords

ADENOVIRUS VECTOR; MAGNETIC NANOPARTICLE;

ADENOVIRUS; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLOW RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; ISOTOPE LABELING; MAGNETIC FIELD; MATERIAL COATING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SURFACE CHARGE; VIRAL GENE DELIVERY SYSTEM; VIRUS CELL INTERACTION; VIRUS INACTIVATION; VIRUS PARTICLE; ZETA POTENTIAL;

ADENOVIRIDAE; ENDOTHELIAL CELLS; ERYTHROCYTES; GENETIC VECTORS; HUMANS; MAGNETICS; NANOPARTICLES; POLYETHYLENE GLYCOLS; STATIC ELECTRICITY; TRANSDUCTION, GENETIC;

EID: 84862677966     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-011-0631-2     Document Type: Article

References (49)

1. Mitani K, Graham FL, Caskey CT, Kochanek S. Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci U S A. 1995;92:3854-8.
2. Parks RJ, Chen L, Anton M, Sankar U, Rudnicki MA, Graham FL. A helper-dependent adenovirus system: removal of helper virus by Cre-mediated excision of viral packaging signal. Proc Natl Acad Sci U S A. 1996;93:13565-70.
3. Eto Y, Gao JQ, Sekiguchi F, Kurachi S, Katayama K, Mizuguchi H, et al. Neutralizing antibody evasion ability of adenovirus vector induced by the bioconjugation of methoxypolyethylene glycol succinimidyl propionate (MPEG-SPA). Biol Pharm Bull. 2004;27:936-8.
4. Suzuki-Kouyama E, Katayama K, Sakurai F, Yamaguchi T, Kurachi S, Kawabata K, et al. Hexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interaction. Biomaterials. 2011;32:1724-30.
5. Park JW, Mok H, Park TG. Physical adsorption of PEG grafted and blocked poly-L-lysine copolymers on adenovirus surface for enhanced gene transduction. J Control Release. 2010;142:238-44.
6. Nettelbeck DM, Miller DW, Jerome V, Zuzarte M, Watkins SJ, Hawkins RE, et al. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105). Mol Ther. 2001;3:882-91.
7. Morishita K, Johnson DE, Williams LT. A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. J Biol Chem. 1995;270:27948-53.
8. Nicklin SA, Reynolds PN, Brosnan MJ, White SJ, Curiel DT, Dominiczak AF, et al. Analysis of cell-specific promoters for viral gene therapy targeted at the vascular endothelium. Hypertension. 2001;38:65-70.
9. Denby L, Work LM, Graham D, Hsu C, von Seggern DJ, Nicklin SA, et al. Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivo. Hum Gene Ther. 2004;15:1054-64.
10. Nicklin SA, Wu E, Nemerow GR, Baker AH. The influence of adenovirus fiber structure and function on vector development for gene therapy. Mol Ther. 2005;12:384-93.
11. Shinozaki K, Suominen E, Carrick F, Sauter B, Kahari VM, Lieber A, et al. Efficient infection of tumor endothelial cells by a capsid-modified adenovirus. Gene Ther. 2006;13:52-9.
12. Nicklin SA, Von Seggern DJ, Work LM, Pek DC, Dominiczak AF, Nemerow GR, et al. Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus. Mol Ther. 2001;4:534-42.
13. Nicklin SA, White SJ, Nicol CG, Von Seggern DJ, Baker AH. In vitro and in vivo characterisation of endothelial cell selective adenoviral vectors. J Gene Med. 2004;6:300-8.
14. O'Riordan CR, Lachapelle A, Delgado C, Parkes V, Wadsworth SC, Smith AE, et al. PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. Hum Gene Ther. 1999;10:1349-58.
15. Croyle MA, Chirmule N, Zhang Y, Wilson JM. PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Hum Gene Ther. 2002;13:1887-900.
16. Kreppel F, Kochanek S. Modification of adenovirus gene transfer vectors with synthetic polymers: a scientific review and technical guide. Mol Ther. 2008;16:16-29.
17. Fisher KD, Stallwood Y, Green NK, Ulbrich K, Mautner V, Seymour LW. Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies. Gene Ther. 2001;8:341-8.
18. Mok H, Palmer DJ, Ng P, Barry MA. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther. 2005;11:66-79.
19. Ogawara K, Rots MG, Kok RJ, Moorlag HE, Van Loenen AM, Meijer DK, et al. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo. Hum Gene Ther. 2004;15:433-43.
20. Parker AL, Fisher KD, Oupicky D, Read ML, Nicklin SA, Baker AH, et al. Enhanced gene transfer activity of peptide-targeted gene-delivery vectors. J Drug Target. 2005;13:39-51.
21. Espenlaub S, Corjon S, Engler T, Fella C, Ogris M, Wagner E, et al. Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modifications. Hum Gene Ther. 2010;21:1155-67.
22. Kreppel F, Gackowski J, Schmidt E, Kochanek S. Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors. Mol Ther. 2005;12:107-17.
23. Arcasoy SM, Latoche JD, Gondor M, Pitt BR, Pilewski JM. Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 1997;4:32-8.
24. Fasbender A, Zabner J, Chillon M, Moninger TO, Puga AP, Davidson BL, et al. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo. J Biol Chem. 1997;272:6479-89.
25. Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Kruger A, et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 2002;9:102-9.
26. Tresilwised N, Pithayanukul P, Mykhaylyk O, Holm PS, Holzmuller R, Anton M, et al. Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force. Mol Pharm. 2010;7:1069-89.
27. Sanchez-Antequera Y, Mykhaylyk O, van Til NP, Cengizeroglu A, de Jong JH, Huston MW, Anton M, Johnston IC, Pojda Z, Wagemaker G, Plank C. Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells. Blood. 2011;117:e171-181.
28. Chorny M, Fishbein I, Alferiev I, Levy RJ. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Mol Pharm. 2009;6:1380-7.
29. Bhattarai SR, Kim SY, Jang KY, Lee KC, Yi HK, Lee DY, et al. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line. J Virol Methods. 2008;147:213-8.
30. Hashimoto M, Hisano Y. Directional gene-transfer into the brain by an adenoviral vector tagged with magnetic nanoparticles. J Neurosci Methods. 2011;194:316-20.
31. Bhattarai SR, Kim SY, Jang KY, Lee KC, Yi HK, Lee DY, et al. N-hexanoyl chitosan-stabilized magnetic nanoparticles: enhancement of adenoviral-mediated gene expression both in vitro and in vivo. Nanomedicine. 2008;4:146-54.
32. Finsinger D, Remy JS, Erbacher P, Koch C, Plank C. Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther. 2000;7:1183-92.
33. Honig D, DeRouchey J, Jungmann R, Koch C, Plank C, Radler JO. Biophysical characterization of copolymer-protected gene vectors. Biomacromolecules. 2010;11:1802-9.
34. Schillinger U, Wexel G, Hacker C, Kullmer M, Koch C, Gerg M, et al. A fibrin glue composition as carrier for nucleic Acid vectors. Pharm Res. 2008;25:2946-62.
35. Scherer F, Schillinger U, Putz U, Stemberger A, Plank C. Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J Gene Med. 2002;4:634-43.
36. Ng P, Parks RJ, Cummings DT, Evelegh CM, Graham FL. An enhanced system for construction of adenoviral vectors by the two- plasmid rescue method. Hum Gene Ther. 2000;11:693-9.
37. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52:456-67.
38. Mykhaylyk O, Sanchez-Antequera Y, Vlaskou D, Hammerschmid E, Anton M, Zelphati O, et al. Liposomal magnetofection. Meth Mol Biol. 2010;605:487-525.
39. Mykhaylyk O, Zelphati O, Rosenecker J, Plank C. siRNA delivery by magnetofection. Curr Opin Mol Ther. 2008;10:493-505.
40. Carlisle RC, Di Y, Cerny AM, Sonnen AF, Sim RB, Green NK, et al. Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1. Blood. 2009;113:1909-18.
41. Mykhaylyk O, Sobisch T, Anton M, Brandt S, Döblinger M, Eberbeck D, Almstätter I, Settles M, Braren R, Lerche D, Plank C. Silica-iron oxide magnetic nanoparticles modified for gene delivery. Search for optimum and quantitative criteria. Pharm Res (2011) accepted
42. Chorny M, Fishbein I, Alferiev IS, Nyanguile O, Gaster R, Levy RJ. Adenoviral gene vector tethering to nanoparticle surfaces results in receptor-independent cell entry and increased transgene expression. Mol Ther. 2006;14:382-91.
43. Tresilwised N, Pithayanukul P, Holm PS, Schillinger U, Plank C, Mykhaylyk O. Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes. Biomaterials (2011) Oct 4. [Epub ahead of print]. doi:10.1016/j.biomaterials.2011.09.28
44. de Graaff JC, Ubbink DT, Lagarde SM, Jacobs MJ. The feasibility and reliability of capillary blood pressure measurements in the fingernail fold. Microvasc Res. 2002;63:270-8.
45. Immer FF, Seiler AM, Aeschbacher BC, Mahler F, Saner H. Influence of the ultrasound contrast agent Levovist on human nailfold capillary microcirculation. Angiology. 2000;51:123-9.
46. Vlaskou D, Mykhaylyk O, Krotz F, Hellwig N, Renner R, Schillinger U, et al. Magnetic and Acoustically Active Lipospheres for Magnetically Targeted Nucleic Acid Delivery. Adv Funct Mater. 2010;20:3881-94.
47. Danielsson A, Elgue G, Nilsson BM, Nilsson B, Lambris JD, Totterman TH, et al. An ex vivo loop system models the toxicity and efficacy of PEGylated and unmodified adenovirus serotype 5 in whole human blood. Gene Ther. 2010;17:752-62.
48. Perez JM, Simeone FJ, Saeki Y, Josephson L, Weissleder R. Viral-induced self-assembly of magnetic nanoparticles allows the detection of viral particles in biological media. J Am Chem Soc. 2003;125:10192-3.
49. Huh YM, Lee ES, Lee JH, Jun YW, Kim PH, Yun CO, et al. Hybrid nanoparticles for magnetic resonance imaging of target-specific viral gene delivery. Adv Mater. 2007;19:3109-12.